One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1136/jitc-2023-007047
Copy DOI
Export
Save
Share
Cite Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: Oct 1, 2023 |
 Citations: 3 |  License type: CC BY-NC 4.0 |
Affiliation: Tongji University, Shanghai Pulmonary Hospital, Roche (Canada), Clemenshospital Münster, Niigata Cancer Center Hospital, Amunix (United States), Ivano-Frankivsk National Medical University, Stanford University, LungenClinic Grosshansdorf, Norton Healthcare, Gilead Sciences (United States), Sapporo National Hospital, National Hospital Organization Hokkaido Medical Center, Vall d'Hebron Hospital Universitari, Roche (United Kingdom), Northwest Behavioral Medicine, Cornell University, New York Hospital Queens, NewYork–Presbyterian Hospital, Presbyterian Hospital, University of Turin, Ospedale San Luigi Gonzaga
BackgroundTumor samples from the phase III IMpower010 study were used to compare two programmed death-ligand 1 (PD-L1) immunohistochemistry assays (VENTANA SP263 and Dako 22C3) for identification of PD-L1 patient subgroups...
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
